“Stories of Hope” shares the stories of the people and scientists at the forefront of advancing medical science and pushing ...

United StatesAurum Capital has launched its Investment-Driven Medical Innovation Initiative, aiming to expand research ...

By Yadarisa Shabong Jan 20 (Reuters) - Britain's GSK and Japan's Shionogi said on Tuesday that Pfizer will exit their HIV ...

By Michael Erman and Christy Santhosh Jan 20 (Reuters) - Novavax said on Tuesday it signed a licensing agreement allowing ...

Novavax’s Pfizer Matrix-M licensing deal brings $30M upfront, milestones & royalties. Read the full analysis here.

The healthcare giant has had trouble winning over investors in the past year despite an incredibly low valuation.

Jan 20 (Reuters) - Japan's Shionogi & Co said on Tuesday it would pay $2.13 billion for new shares in ViiV Healthcare, its ...

Pfizer is also making strides in the weight management market. It now owns one of the more promising mid-stage assets in this ...

Multiple companies and organizations have announced early results about their COVID-19 vaccines. Here's what we know about ...

Pfizer has outperformed the S&P 500 since my previous call, driven by improving fundamentals and renewed share price momentum ...

At WSJ Journal House in Davos, Albert Bourla describes how discussions with the U.S. Secretary of Health and Human Services ...

Pfizer CEO Albert Bourla criticizes RFK's vaccine stance, warns US health research is losing ground to China, and urges ...